[NRSKarenRN]

P.L.C. SAID IT WOULD USE A SITE IN
PENNSYLVANIA TO DEVELOP NEW WAYS TO MAKE FLU VACCINE.

GlaxoSmithKline has bought a shuttered vaccine plant in
Pa.'s Lancaster County and said it will invest at least
$100 million to buy and upgrade the 90-acre
manufacturing site previously owned by Wyeth, reported
the Inquirer. The plant offers GlaxoSmithKline a
foothold in the U.S. market for vaccine production that
it now handles exclusively abroad, while company
officials said they initially will use the plant to
develop a new technology to make flu vaccines and, if
successful, will then ramp up the site for production,
the Inquirer added.

Philadelphia Inquirer, September 2, 2005
http://www.philly.com/mld/inquirer/b...s/12538720.htm

[Jessy_RN]

This sounds like a good thing.